10X Genomics Inc reports results for the quarter ended in June - Earnings Summary

10x Genomics

03/08/2023 22:50

* 10X Genomics Inc  TXG.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in June. The mean
expectation of fourteen analysts for the quarter was for a loss
of 40 cents per share.
    * Revenue rose 28.1% to $146.82 million from a year ago;
analysts
expected $139.96 million. 
    * 10X Genomics Inc's reported EPS for the quarter was a loss
of 53
cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * 10X Genomics Inc shares had risen by 5.1% this quarter and
gained 61.1% so far this year.
    * The company reported a quarterly loss of $62.41 million.
    * Wall Street's median 12-month price target for 10X
Genomics Inc
is $65.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 09:50 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.40          -0.53          Missed
 Mar. 31 2023      -0.37          -0.44          Missed
 Dec. 31 2022      -0.31          -0.15          Beat
 Sep. 30 2022      -0.46          -0.37          Beat